Cormorant Asset Management LP 13D and 13G filings for Avidity Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-12-27 4:15 pm Purchase |
2022-12-14 | 13G | Avidity Biosciences, Inc. RNA |
Cormorant Asset Management LP | 2,762,115 5.070% |
750,000 (+37.27%) |
Filing |
| 2022-02-14 3:06 pm Sale |
2021-12-31 | 13G | Avidity Biosciences, Inc. RNA |
Cormorant Asset Management LP | 2,012,115 4.290% |
-452,432 (-18.36%) |
Filing |
| 2021-02-16 3:10 pm Sale |
2020-12-31 | 13G | Avidity Biosciences, Inc. RNA |
Cormorant Asset Management LP | 2,464,547 6.570% |
-49,998 (-1.99%) |
Filing |
| 2020-06-26 4:17 pm Purchase |
2020-06-16 | 13G | Avidity Biosciences, Inc. RNA |
Cormorant Asset Management LP | 2,514,545 6.700% |
2,514,545 (New Position) |
Filing |